Inventor
Reinhold Mueller
Inventor
Schifferstadt, DE
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides18%
A61KPreparations for medical, dental or toiletry purposes15%
C07DHeterocyclic compounds9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
Y02ATechnologies for adaptation to climate change9%
C07HSugars7%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C12NMicroorganisms or enzymes2%
PatentTitleYear
10,738,359Methods and processes for non-invasive assessment of genetic variations202010,464,976Amyloid b(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof201910,040,852Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof20189,605,313'Methods and processes for non-invasive assessment of genetic variations'20179,394,363'Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof'20169,255,146'Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof'20169,176,150'Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof'20158,906,864'Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use'20148,323,651'Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof'20128,283,148'DNA polymerase compositions for quantitative PCR and methods thereof'20127,906,120'Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)'20117,491,729'3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof'20097,361,469'Dual labeled fluorescent probes'20087,041,675'Heterocyclic compounds and their use as PARP inhibitors'20067,026,311'Dibenzodiazepine derivatives, their preparation and use'20066,737,421'Cyclo-alkyl substituted benzimidazoles and their use as PARP inhibitors'20046,696,437'Heterocyclically substituted benzimidazoles, the production and application thereof'20046,063,604'Target nucleic acid sequence amplification'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000Based in Wauwatosa, WI, US· patent location history
2004–2012Patents assigned to ABBOTT GMBH & CO KG (6)· patent assignee history
2004–2019Based in Schifferstadt, DE· patent location history
2008–2020Based in San Diego, CA, US· patent location history
2011–2012Patents assigned to ABBOTT LAB (2)· patent assignee history
2012–2015Patents assigned to MUELLER REINHOLD (3)· patent assignee history
2014–2019Patents assigned to ABBVIE DEUTSCHLAND (6)· patent assignee history
2016–2018Patents assigned to ABBVIE INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBOTT GMBH & CO KG | 6 | 2004–2012 |
| ABBVIE DEUTSCHLAND | 6 | 2014–2019 |
| ABBVIE INC | 3 | 2016–2018 |
| MUELLER REINHOLDself | 3 | 2012–2015 |
| ABBOTT LAB | 2 | 2011–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Schifferstadt, DE | 13 | 2004–2019 |
| San Diego, California, US | 4 | 2008–2020 |
| Wauwatosa, WI, US | 1 | 2000 |